XBiotech Company Overview, Contact Details & Competitors

Q: What is XBiotech's official website and social media links?

XBiotech's official website is favrille.com. XBiotech has social profiles on LinkedIn.

Q: How many employees does XBiotech have currently?

XBiotech has approximately 51 employees.

Q: What technology does XBiotech use?

XBiotech's tech stack includes LiteSpeed, Moment.js, HTTP/3, Shopify, JSON-LD.

Insights

Gathering insights about XBiotech…

Similar companies to XBiotech

XBiotech Tech Stack

XBiotech uses 8 technology products and services including WordPress, Open Graph, JSON-LD, and more. Explore XBiotech's tech stack below.

WordPress
Content Management System
Open Graph
Content Management System
JSON-LD
Javascript Frameworks
Moment.js
Javascript Libraries
jQuery
Javascript Libraries
Yoast SEO
Search Engines
HTTP/3
Web & Portal Technology
Contact Form 7
Web Platform Extensions

Media & News

XBiotech (NASDAQ:XBIT) Share Price Crosses Above Fifty Day Moving Average – Should You Sell?
XBiotech Inc. (NASDAQ: XBIT - Get Free Report) passed above its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $2.47 and traded as high as $2.68. XBiotech shares last traded at $2.48, with a volume of 87,170 shares changing hands. Analyst Upgrades and Downgrades Separately, Weiss
Dec 06, 2025 | www.defenseworld.net
The Schall Law Firm Invites Shareholders With Losses In XBiotech Inc. To Join A Securities Fraud Investigation
LOS ANGELES, CA / ACCESS Newswire / March 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of XBiotech Inc. ("XBiotech" or "the Company") (NASDAQ:XBIT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Mar 02, 2025 | www.accessnewswire.com
An Investigation Has Been Launched Into XBiotech Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / March 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of XBiotech Inc. ("XBiotech" or "the Company") (NASDAQ:XBIT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Mar 01, 2025 | www.accessnewswire.com
The Schall Law Firm Invites Shareholders With Losses In XBiotech Inc. To Join A Securities Fraud Investigation
LOS ANGELES, CA / ACCESS Newswire / February 28, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of XBiotech Inc. ("XBiotech" or "the Company") (NASDAQ:XBIT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Feb 28, 2025 | www.accessnewswire.com
An Investigation Has Been Launched Into XBiotech Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / February 27, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of XBiotech Inc. ("XBiotech" or "the Company") (NASDAQ:XBIT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Feb 27, 2025 | www.accessnewswire.com
The Schall Law Firm Invites Shareholders With Losses In XBiotech Inc. To Join A Securities Fraud Investigation
LOS ANGELES, CA / ACCESS Newswire / February 26, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of XBiotech Inc. ("XBiotech" or "the Company") (NASDAQ:XBIT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Feb 26, 2025 | www.accessnewswire.com
An Investigation Has Been Launched Into XBiotech Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of XBiotech Inc. ("XBiotech" or "the Company") (NASDAQ:XBIT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Feb 25, 2025 | www.accessnewswire.com

XBiotech's Email Address Formats

XBiotech uses at least 1 format(s):

XBiotech Email Formats	Example	Percentage
FLast@favrille.com	JDoe@favrille.com	43%
First.Last@favrille.com	John.Doe@favrille.com	7%
FLast@favrille.com	JDoe@favrille.com	43%
First.Last@favrille.com	John.Doe@favrille.com	7%

Frequently Asked Questions

Where is XBiotech's headquarters located?

XBiotech's main headquarters is located at United States. The company has employees across 1 continents, including North America.

What is XBiotech's stock symbol?

XBiotech is a publicly traded company; the company's stock symbol is XBIT.

What is XBiotech's official website and social media links?

XBiotech's official website is favrille.com and has social profiles on LinkedIn.

What is XBiotech's SIC code NAICS code?

XBiotech's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does XBiotech have currently?

As of February 2026, XBiotech has approximately 51 employees across 1 continents, including North America. Key team members include Chief Scientist Officer: D. G.Vp Regulatory Affairs Quality: A. W.Director Of Operations: S. D.. Explore XBiotech's employee directory with LeadIQ.

What industry does XBiotech belong to?

XBiotech operates in the Biotechnology Research industry.

What technology does XBiotech use?

XBiotech's tech stack includes WordPressOpen GraphJSON-LDMoment.jsjQueryYoast SEOHTTP/3Contact Form 7.

What is XBiotech's email format?

XBiotech's email format typically follows the pattern of FLast@favrille.com. Find more XBiotech email formats with LeadIQ.

Insights

Similar companies to XBiotech

Etsy

Zazzle

Gooten

TeePublic

Printify

Society6

Custom Ink

Redbubble

Printful

XBiotech Tech Stack

Media & News

XBiotech (NASDAQ:XBIT) Share Price Crosses Above Fifty Day Moving Average – Should You Sell?

The Schall Law Firm Invites Shareholders With Losses In XBiotech Inc. To Join A Securities Fraud Investigation

An Investigation Has Been Launched Into XBiotech Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm

The Schall Law Firm Invites Shareholders With Losses In XBiotech Inc. To Join A Securities Fraud Investigation

An Investigation Has Been Launched Into XBiotech Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm

The Schall Law Firm Invites Shareholders With Losses In XBiotech Inc. To Join A Securities Fraud Investigation

An Investigation Has Been Launched Into XBiotech Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm

XBiotech's Email Address Formats

Frequently Asked Questions

Where is XBiotech's headquarters located?

What is XBiotech's stock symbol?

What is XBiotech's official website and social media links?

What is XBiotech's SIC code NAICS code?

How many employees does XBiotech have currently?

What industry does XBiotech belong to?

What technology does XBiotech use?

What is XBiotech's email format?

XBiotech

Company Overview

Media & News

XBiotech (NASDAQ:XBIT) Share Price Crosses Above Fifty Day Moving Average – Should You Sell?

The Schall Law Firm Invites Shareholders With Losses In XBiotech Inc. To Join A Securities Fraud Investigation

An Investigation Has Been Launched Into XBiotech Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?